{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:13:21Z","timestamp":1792458801827,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymgme.2025.109220","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:23:32Z","timestamp":1754954612000},"page":"109220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elamipretide in the Management of Barth Syndrome: Current Evidence and a Case Report"],"prefix":"10.1016","volume":"146","author":[{"given":"Neil","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schecter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Lamour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elsharkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109220_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109220_bb0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/iub.2018","article-title":"Mitochondrial dysfunctions in Barth syndrome","volume":"71","author":"Ghosh","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ymgme.2025.109220_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2019.09.074","article-title":"A Bayesian analysis to determine the prevalence of barth syndrome in the pediatric population","volume":"217","author":"Miller","year":"2020","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/pd.1438","article-title":"X-linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene","volume":"26","author":"Brady","year":"2006","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ymgme.2025.109220_bb0025","series-title":"GeneReviews\u00ae","article-title":"Barth syndrome","author":"Ferreira","year":"1993"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymgme.2012.09.013","article-title":"Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle","volume":"107","author":"Ronvelia","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10741-020-10031-3","article-title":"Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide","volume":"26","author":"Sabbah","year":"2021","journal-title":"Heart Fail. Rev."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0040","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","article-title":"The Barth syndrome registry: distinguishing disease characteristics and growth data from a longitudinal study","volume":"158A","author":"Roberts","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2025.109220_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of Barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00246-015-1260-z","article-title":"Clinical characteristics and outcomes of cardiomyopathy in Barth syndrome: The UK experience","volume":"37","author":"Kang","year":"2016","journal-title":"Pediatr. Cardiol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0055","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1542\/peds.2005-2667","article-title":"Cardiac and clinical phenotype in Barth syndrome","volume":"118","author":"Spencer","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pd.2599","article-title":"Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth","volume":"30","author":"Steward","year":"2010","journal-title":"Prenat. Diagn."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0065","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00246-022-02846-8","article-title":"Longitudinal observational study of cardiac outcome risk factor prediction in children, adolescents, and adults with Barth syndrome","volume":"43","author":"Chowdhury","year":"2022","journal-title":"Pediatr. Cardiol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2217\/fca-2023-0008","article-title":"Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide","volume":"19","author":"Sabbah","year":"2023","journal-title":"Futur. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jimd.12453","article-title":"Current and future treatment approaches for Barth syndrome","volume":"45","author":"Thompson","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13023-021-01897-z","article-title":"Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adults","volume":"16","author":"Gwaltney","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0085","doi-asserted-by":"crossref","first-page":"H2122","DOI":"10.1152\/ajpheart.00479.2010","article-title":"Impaired cardiac reserve and severely diminished skeletal muscle O\u2082 utilization mediate exercise intolerance in Barth syndrome","volume":"301","author":"Spencer","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","article-title":"Skeletal muscle inflammation and atrophy in heart failure","volume":"22","author":"Lavine","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.CIR.80.5.1338","article-title":"Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure","volume":"80","author":"Mancini","year":"1989","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0100","article-title":"Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome","volume":"5","author":"Bashir","year":"2017","journal-title":"Phys. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10545-012-9486-x","article-title":"Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome","volume":"36","author":"Cade","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Pt 2","key":"10.1016\/j.ymgme.2025.109220_bb0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1113\/jphysiol.2005.097782","article-title":"Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle","volume":"569","author":"Marcinek","year":"2005","journal-title":"J. Physiol."},{"issue":"15","key":"10.1016\/j.ymgme.2025.109220_bb0115","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/01.CIR.102.15.1847","article-title":"Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle","volume":"102","author":"De Sousa","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0120","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.87.5.1729","article-title":"Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure","volume":"87","author":"Sabbah","year":"1993","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0125","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0735-1097(94)00568-B","article-title":"Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles","volume":"25","author":"Hambrecht","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0130","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0735-1097(97)00015-6","article-title":"Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure","volume":"29","author":"Hambrecht","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOH.0000000000000472","article-title":"Neutropenia in Barth syndrome: characteristics, risks, and management","volume":"26","author":"Steward","year":"2019","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmb.2006.06.057","article-title":"Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients","volume":"361","author":"McKenzie","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0145","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1091\/mbc.e05-03-0256","article-title":"Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome","volume":"16","author":"Brandner","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOH.0b013e32831c83f3","article-title":"Mitochondrial defects lie at the basis of neutropenia in Barth syndrome","volume":"16","author":"Van Raam","year":"2009","journal-title":"Curr. Opin. Hematol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/DBP.0b013e31824c4090","article-title":"Emergence and nature of mathematical difficulties in young children with Barth syndrome","volume":"33","author":"Raches","year":"2012","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ajmg.1487","article-title":"Preliminary evidence for a cognitive phenotype in Barth syndrome","volume":"102","author":"Mazzocco","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.DBP.0000257519.79803.90","article-title":"Barth syndrome is associated with a cognitive phenotype","volume":"28","author":"Mazzocco","year":"2007","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109220_bb0170","article-title":"Quality of life in Barth syndrome","volume":"3","author":"Kim","year":"2022","journal-title":"Ther. Adv. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109220_bb0175","doi-asserted-by":"crossref","first-page":"5588935","DOI":"10.1155\/2023\/5588935","article-title":"The impact of raising children with Barth syndrome on parental health-related quality of life and family functioning: preliminary reliability and validity of the PedsQL\u2122 family impact module","volume":"2023","author":"Lim","year":"2023","journal-title":"Occup. Ther. Int."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-025-03636-0","article-title":"Health-related quality of life and family functioning in parents of children with Barth syndrome: an application of the Double ABCX model","volume":"20","author":"Lim","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109220_bb0185","article-title":"\u201cI want that life a lot\u2026how on earth do i get that?\u201d Examining challenges for men with Barth syndrome in their transitions to adulthood","volume":"8","author":"Mazar","year":"2021","journal-title":"J. Patient. Exp."},{"issue":"18","key":"10.1016\/j.ymgme.2025.109220_bb0190","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1016\/j.jmb.2020.03.026","article-title":"The function of tafazzin, a mitochondrial phospholipid-lysophospholipid acyltransferase","volume":"432","author":"Schlame","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"51","key":"10.1016\/j.ymgme.2025.109220_bb0195","doi-asserted-by":"crossref","first-page":"39217","DOI":"10.1074\/jbc.M606100200","article-title":"The enzymatic function of tafazzin","volume":"281","author":"Xu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0200","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.bbamem.2009.04.019","article-title":"The role of cardiolipin in the structural organization of mitochondrial membranes","volume":"1788","author":"Schlame","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.ymgme.2025.109220_bb0205","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.febslet.2009.07.018","article-title":"Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria","volume":"583","author":"Sorice","year":"2009","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0210","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.freeradbiomed.2010.02.020","article-title":"Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging","volume":"48","author":"Paradies","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0215","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.emboj.7601618","article-title":"Structures and physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase","volume":"26","author":"Shinzawa-Itoh","year":"2007","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0220","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1529\/biophysj.108.136077","article-title":"Membrane deformation under local pH gradient: mimicking mitochondrial cristae dynamics","volume":"95","author":"Khalifat","year":"2008","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","article-title":"Barth syndrome: connecting cardiolipin to cardiomyopathy","volume":"52","author":"Ikon","year":"2017","journal-title":"Lipids"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0230","first-page":"1001","article-title":"New targets for monitoring and therapy in Barth syndrome","volume":"18","author":"Thompson","year":"2016","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ab.2009.01.032","article-title":"Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome","volume":"387","author":"Houtkooper","year":"2009","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2014.03.007","article-title":"Clinical laboratory studies in Barth Syndrome","volume":"112","author":"Vernon","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jimd.12425","article-title":"An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin\/cardiolipin ratio","volume":"45","author":"Vaz","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109220_bb0250","author":"Human Tafazzin Gene Variants Database"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0255","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nm.3545","article-title":"Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.ymgme.2025.109220_bb0260","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: A report of the American college of cardiology solution set oversight committee","volume":"83","author":"Maddox","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ccl.2007.08.004","article-title":"Guidelines for the management of heart failure: differences in guideline perspectives","volume":"25","author":"Jessup","year":"2007","journal-title":"Cardiol. Clin."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajmg.c.31372","article-title":"Barth syndrome","volume":"163C","author":"Jefferies","year":"2013","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"22","key":"10.1016\/j.ymgme.2025.109220_bb0275","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.123.066605","article-title":"Sacubitril\/Valsartan in pediatric heart failure (PANORAMA-HF): a randomized, multicenter, double-blind trial","volume":"150","author":"Shaddy","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0280","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002566","article-title":"Association of digoxin with interstage mortality: results from the pediatric heart network single ventricle reconstruction trial public use dataset","volume":"5","author":"Oster","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109220_bb0290","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.healun.2021.06.017","article-title":"Favorable outcomes after heart transplantation in Barth syndrome","volume":"40","author":"Li","year":"2021","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0295","first-page":"429","article-title":"Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy","volume":"96","author":"Freedman","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0300","first-page":"489","article-title":"New indications and controversies in arginine therapy","volume":"27","author":"Coman","year":"2008","journal-title":"Clin. Nutr. Edinb. Scotl."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0305","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0310","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911589","article-title":"Metabolic effects of bezafibrate in mitochondrial disease","volume":"12","author":"Steele","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109220_bb0315","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial","volume":"82","author":"\u00d8rngreen","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-017-0605-5","article-title":"The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome","volume":"12","author":"Huang","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109220_bb0330","article-title":"Bezafibrate as treatment in males for Barth Syndrome: CARDIOMAN, a double-blind, placebo-controlled crossover RCT","author":"Pieles","year":"2024","journal-title":"Natl. Inst. Health Care Res."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hum.2018.020","article-title":"AAV-Mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in Barth syndrome","volume":"30","author":"Suzuki-Hatano","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109220_bb0340","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome","volume":"126","author":"Wang","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0345","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0355","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0360","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10741-021-10199-2","article-title":"Targeting mitochondrial dysfunction with elamipretide","volume":"27","author":"Obi","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0365","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/jpet.102.040147","article-title":"Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide","volume":"304","author":"Zhao","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"21","key":"10.1016\/j.ymgme.2025.109220_bb0370","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1074\/jbc.RA119.012094","article-title":"The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action","volume":"295","author":"Mitchell","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109220_bb0375","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","article-title":"Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis","volume":"171","author":"Birk","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"33","key":"10.1016\/j.ymgme.2025.109220_bb0380","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury*","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109220_bb0385","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109220_bb0390","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 Re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","article-title":"Abnormalities of mitochondrial dynamics in the failing heart: normalization following long-term therapy with elamipretide","volume":"32","author":"Sabbah","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0400","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/scdb.2001.0282","article-title":"Reactive oxygen species and mitochondrial diseases","volume":"12","author":"Kirkinezos","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.RES.0000109416.56608.64","article-title":"Decrease in mitochondrial complex I activity in ischemic\/reperfused rat heart","volume":"94","author":"Paradies","year":"2004","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0410","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1096\/fj.02-0729fje","article-title":"Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin","volume":"17","author":"Petrosillo","year":"2003","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0415","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-1119(01)00814-9","article-title":"Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage","volume":"286","author":"Paradies","year":"2002","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109220_bb0420","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCRESAHA.108.180869","article-title":"Reactive oxygen species production in energized cardiac mitochondria during hypoxia\/reoxygenation: modulation by nitric oxide","volume":"103","author":"Korge","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0425","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yjmcc.2006.09.013","article-title":"Cyclosporine a attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure","volume":"42","author":"Sharov","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109220_bb0430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10741-005-7545-1","article-title":"Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes","volume":"10","author":"Sharov","year":"2005","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0435","first-page":"C460","article-title":"Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria","volume":"294","author":"Chen","year":"2008","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.ymgme.2025.109220_bb0440","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: The evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymgme.2025.109220_bb0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.physiol.010908.163111","article-title":"Cell death in the pathogenesis of heart disease: mechanisms and significance","volume":"72","author":"Whelan","year":"2010","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0450","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ceca.2009.03.012","article-title":"Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease","volume":"45","author":"Paradies","year":"2009","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002206","article-title":"Chronic therapy with elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure","volume":"9","author":"Sabbah","year":"2016","journal-title":"Circ. Heart Fail."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0460","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic. Transl. Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0465","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s11357-023-00861-y","article-title":"The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)","volume":"45","author":"Pharaoh","year":"2023","journal-title":"GeroScience"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0470","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rco2.29","article-title":"Reduced adenosine diphosphate sensitivity in skeletal muscle mitochondria increases reactive oxygen species production in mouse models of aging and oxidative stress but not denervation","volume":"4","author":"Pharaoh","year":"2021","journal-title":"JCSM Rapid Commun."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0475","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.celrep.2018.02.069","article-title":"Age-associated impairments in mitochondrial ADP sensitivity contribute to redox stress in senescent human skeletal muscle","volume":"22","author":"Holloway","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/acel.12147","article-title":"Mitochondrial energetics is impaired in vivo in aged skeletal muscle","volume":"13","author":"Gouspillou","year":"2014","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0485","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/db18-0417","article-title":"High-fat diet causes mitochondrial dysfunction as a result of impaired ADP sensitivity","volume":"67","author":"Miotto","year":"2018","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.ymgme.2025.109220_bb0490","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1042\/BCJ20180419","article-title":"Mitochondrial-derived reactive oxygen species influence ADP sensitivity, but not CPT-I substrate sensitivity","volume":"475","author":"Barbeau","year":"2018","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0495","first-page":"471","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Reid Thompson","year":"2021","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109220_bb0500","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2018.12.031","article-title":"Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice","volume":"134","author":"Campbell","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0505","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acel.12102","article-title":"Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice","volume":"12","author":"Siegel","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.ymgme.2025.109220_bb0510","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60827","article-title":"Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte","volume":"9","author":"Zhang","year":"2020","journal-title":"eLife"},{"issue":"26","key":"10.1016\/j.ymgme.2025.109220_bb0515","doi-asserted-by":"crossref","first-page":"15363","DOI":"10.1073\/pnas.2002250117","article-title":"Mitochondrial protein interaction landscape of SS-31","volume":"117","author":"Chavez","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109220_bb0520","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/07853890008998837","article-title":"Phospholamban and cardiac contractility","volume":"32","author":"Frank","year":"2000","journal-title":"Ann. Med."},{"issue":"38","key":"10.1016\/j.ymgme.2025.109220_bb0525","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1021\/bi9909445","article-title":"Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase","volume":"38","author":"Viner","year":"1999","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0530","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109220_bb0535","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"16","key":"10.1016\/j.ymgme.2025.109220_bb0540","article-title":"SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin-deficient mice","volume":"7","author":"Braun","year":"2019","journal-title":"Phys. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0545","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0550","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0555","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12012-010-9078-7","article-title":"T lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosis","volume":"10","author":"Zibadi","year":"2010","journal-title":"Cardiovasc. Toxicol."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0560","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/BCJ20170714","article-title":"Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases","volume":"475","author":"Nakayama","year":"2018","journal-title":"Biochem. J."},{"issue":"7285","key":"10.1016\/j.ymgme.2025.109220_bb0565","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109220_bb0570","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003118","article-title":"Restoration of mitochondrial cardiolipin attenuates cardiac damage in swine renovascular hypertension","volume":"5","author":"Eirin","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101005","article-title":"Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules","volume":"297","author":"Anzmann","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0585","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ehf2.12408","article-title":"Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure","volume":"6","author":"Sabbah","year":"2019","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0590","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/FJC.0000000000000155","article-title":"Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats","volume":"64","author":"Dai","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0595","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42003-020-1101-3","article-title":"The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats","volume":"3","author":"Allen","year":"2020","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0600","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s10741-021-10177-8","article-title":"Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid","volume":"27","author":"Sabbah","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109220_bb0605","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","article-title":"Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide","volume":"10","author":"Daubert","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ymgme.2025.109220_bb0610","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55513","article-title":"Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice","volume":"9","author":"Chiao","year":"2020","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0615","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2016070761","article-title":"Mitochondria protection after acute ischemia prevents prolonged upregulation of IL-1\u03b2 and IL-18 and arrests CKD","volume":"28","author":"Szeto","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0620","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/01.CIR.89.6.2852","article-title":"Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction","volume":"89","author":"Sabbah","year":"1994","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ymgme.2025.109220_bb0625","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000005255","article-title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","volume":"90","author":"Karaa","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0630","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","article-title":"Efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy","volume":"101","author":"Karaa","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0635","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.pharmthera.2013.07.005","article-title":"Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia\/reperfusion injury","volume":"140","author":"Brown","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109220_bb0640","article-title":"Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER","volume":"26","author":"Thompson","year":"2024","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0645","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3928\/19425864-20150422-04","article-title":"Comparison of the SWAY balance mobile application to the abbreviated balance error scoring system","volume":"7","author":"Amick","year":"2015","journal-title":"Athl. Train Sports Health Care"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109220_bb0650","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/JSM.0000000000000632","article-title":"Normative Data for the sway balance system","volume":"30","author":"Brett","year":"2020","journal-title":"Clin. J. Sport Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0655","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13023-022-02469-5","article-title":"Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome","volume":"17","author":"Hornby","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0660","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13023-021-01805-5","article-title":"The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases","volume":"16","author":"Tandon","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109220_bb0665","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/biology10060510","article-title":"Test-retest reliability of five times sit to stand test (FTSST) in adults: a systematic review and meta-analysis","volume":"10","author":"Mu\u00f1oz-Bermejo","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.ymgme.2025.109220_bb0670","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/11.suppl_C.30","article-title":"Diastolic dysfunction and myocardial energetics","volume":"11 Suppl C","author":"Pouleur","year":"1990","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymgme.2025.109220_bb0675","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fgene.2015.00003","article-title":"Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes","volume":"6","author":"Lu","year":"2015","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109220_bb0680","first-page":"65","article-title":"Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases","volume":"64","author":"Koenig","year":"2023","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0685","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molcel.2017.06.013","article-title":"Acylglycerol kinase mutated in sengers syndrome is a subunit of the TIM22 protein translocase in mitochondria","volume":"67","author":"Vukotic","year":"2017","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109220_bb0690","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2017.06.014","article-title":"Sengers syndrome-associated mitochondrial acylglycerol kinase is a subunit of the human TIM22 protein import complex","volume":"67","author":"Kang","year":"2017","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109220_bb0695","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1074\/jbc.M110.171439","article-title":"Cardiac and skeletal muscle defects in a mouse model of human barth syndrome","volume":"286","author":"Acehan","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:03:18Z","timestamp":1761433398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":139,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1096719225002112"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109220","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elamipretide in the Management of Barth Syndrome: Current Evidence and a Case Report","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109220"}}